JP2008511608A - 髄膜炎菌外膜ベシクルに関する改良 - Google Patents

髄膜炎菌外膜ベシクルに関する改良 Download PDF

Info

Publication number
JP2008511608A
JP2008511608A JP2007529033A JP2007529033A JP2008511608A JP 2008511608 A JP2008511608 A JP 2008511608A JP 2007529033 A JP2007529033 A JP 2007529033A JP 2007529033 A JP2007529033 A JP 2007529033A JP 2008511608 A JP2008511608 A JP 2008511608A
Authority
JP
Japan
Prior art keywords
omv
composition
meningococcal
serum
subtype
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007529033A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008511608A5 (enExample
Inventor
フィリップ オステル，
リノ ラプッオリ，
マリアグラツィア ピッツァ，
Original Assignee
ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル filed Critical ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル
Publication of JP2008511608A publication Critical patent/JP2008511608A/ja
Publication of JP2008511608A5 publication Critical patent/JP2008511608A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
JP2007529033A 2004-09-03 2005-09-05 髄膜炎菌外膜ベシクルに関する改良 Pending JP2008511608A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0419627.5A GB0419627D0 (en) 2004-09-03 2004-09-03 Immunogenic bacterial vesicles with outer membrane proteins
PCT/IB2005/002801 WO2006024946A2 (en) 2004-09-03 2005-09-05 Improvements relating to meningococcal outer membrane vesicles

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011185225A Division JP2011236254A (ja) 2004-09-03 2011-08-26 髄膜炎菌外膜ベシクルに関する改良

Publications (2)

Publication Number Publication Date
JP2008511608A true JP2008511608A (ja) 2008-04-17
JP2008511608A5 JP2008511608A5 (enExample) 2011-10-13

Family

ID=33156002

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007529033A Pending JP2008511608A (ja) 2004-09-03 2005-09-05 髄膜炎菌外膜ベシクルに関する改良
JP2011185225A Pending JP2011236254A (ja) 2004-09-03 2011-08-26 髄膜炎菌外膜ベシクルに関する改良

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011185225A Pending JP2011236254A (ja) 2004-09-03 2011-08-26 髄膜炎菌外膜ベシクルに関する改良

Country Status (13)

Country Link
US (1) US8808711B2 (enExample)
EP (1) EP1784213B1 (enExample)
JP (2) JP2008511608A (enExample)
CN (2) CN101115501A (enExample)
AU (1) AU2005278896B2 (enExample)
BR (1) BRPI0514883A (enExample)
CA (1) CA2578588A1 (enExample)
ES (1) ES2527859T3 (enExample)
GB (1) GB0419627D0 (enExample)
MX (1) MX2007002633A (enExample)
NZ (1) NZ553521A (enExample)
RU (1) RU2420312C2 (enExample)
WO (1) WO2006024946A2 (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9513371D0 (en) * 1995-06-30 1995-09-06 Biocine Spa Immunogenic detoxified mutant toxins
EP1860191A3 (en) 1999-05-19 2008-02-13 Novartis Vaccines and Diagnostics S.r.l. Combination neisserial compositions
GB9928196D0 (en) 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
GB0316560D0 (en) 2003-07-15 2003-08-20 Chiron Srl Vesicle filtration
GB0408977D0 (en) * 2004-04-22 2004-05-26 Chiron Srl Immunising against meningococcal serogroup Y using proteins
GB0424092D0 (en) 2004-10-29 2004-12-01 Chiron Srl Immunogenic bacterial vesicles with outer membrane proteins
US10828361B2 (en) * 2006-03-22 2020-11-10 Glaxosmithkline Biologicals Sa Regimens for immunisation with meningococcal conjugates
CA2646993C (en) 2006-03-22 2016-01-26 Novartis Ag Regimens for immunisation with meningococcal conjugates
NZ584683A (en) 2007-10-19 2012-05-25 Novartis Ag Neisseria meningitidis serogroup B vaccine formulations
PL2268618T3 (pl) 2008-03-03 2015-11-30 Novartis Ag Związki i kompozycje jako modulatory aktywności receptorów TLR
US9387239B2 (en) * 2008-05-30 2016-07-12 U.S. Army Medical Research And Materiel Command Meningococcal multivalent native outer membrane vesicle vaccine, methods of making and use thereof
GB0822634D0 (en) * 2008-12-11 2009-01-21 Novartis Ag Meningitis vaccines
BRPI0923006A2 (pt) 2008-12-17 2016-03-08 Novartis Ag vacinas meningococicas incluindo receptor de hemoglobina
CN102762226A (zh) 2009-06-10 2012-10-31 诺华有限公司 含苯并萘啶的疫苗
CN102740882A (zh) 2009-08-27 2012-10-17 诺华有限公司 含有铝、寡核苷酸和聚阳离子的佐剂
JO3257B1 (ar) 2009-09-02 2018-09-16 Novartis Ag مركبات وتركيبات كمعدلات لفاعلية tlr
ES2443952T3 (es) 2009-09-02 2014-02-21 Novartis Ag Composiciones inmunógenas que incluyen moduladores de la actividad de TLR
WO2011057148A1 (en) 2009-11-05 2011-05-12 Irm Llc Compounds and compositions as tlr-7 activity modulators
US9408907B2 (en) 2009-12-15 2016-08-09 Glaxosmithkline Biologicals Sa Homogenous suspension of immunopotentiating compounds and uses thereof
WO2012020326A1 (en) 2010-03-18 2012-02-16 Novartis Ag Adjuvanted vaccines for serogroup b meningococcus
JP5848748B2 (ja) 2010-03-23 2016-01-27 アイアールエム・リミテッド・ライアビリティ・カンパニーＩｒｍ，Ｌｌｃ 感染症、炎症、呼吸器疾患などの処置に使用するｔｌｒ２アゴニストとしての化合物（システインベースのリポペプチド）および組成物
AU2011300418B2 (en) 2010-09-10 2016-05-12 Glaxosmithkline Biologicals Sa Meningococcus overexpressing NadA and/or NHBA and outer membrane vesicles derived therefrom
WO2012153302A1 (en) 2011-05-12 2012-11-15 Novartis Ag Antipyretics to enhance tolerability of vesicle-based vaccines
MX2014008988A (es) 2012-02-02 2014-08-27 Novartis Ag Promotores para aumento de expresion de proteinas en meningococo.
US10598666B2 (en) 2012-03-08 2020-03-24 Glaxosmithkline Biologicals Sa In vitro potency assay for protein-based meningococcal vaccines
EP2833911A4 (en) 2012-04-06 2016-07-13 Univ Cornell SUB-VACCINE VACCINATING PLATFORM FOR ROBUST HUMORAL AND CELLULAR IMMUNE RESPONSES
US10376573B2 (en) 2012-06-14 2019-08-13 Glaxosmithkline Biologicals Sa Vaccines for serogroup X meningococcus
RU2015106930A (ru) 2012-09-06 2016-10-20 Новартис Аг Комбинированные вакцины с менингококком серогруппы в и к/д/с
RU2662970C2 (ru) 2012-09-18 2018-07-31 Новартис Аг Везикулы наружной мембраны
US20160120818A1 (en) 2013-02-07 2016-05-05 Glaxosmithline Biological Sa Pharmaceutical compositions comprising vesicles
CA2940447C (en) 2014-02-28 2023-07-11 Glaxosmithkline Biologicals Sa Modified meningococcal fhbp polypeptides
EA201692552A1 (ru) 2014-07-17 2017-06-30 Глаксосмитклайн Байолоджикалс С.А. МОДИФИЦИРОВАННЫЕ МЕНИНГОКОККОВЫЕ ПОЛИПЕПТИДЫ fHbp
AR101225A1 (es) 2014-07-17 2016-11-30 Glaxosmithkline Biologicals Sa Vacunas de meningococos
KR101742236B1 (ko) * 2014-10-29 2017-05-31 인하대학교 산학협력단 쯔쯔가무시병에 대한 면역 조성물 및 이의 제조방법
CN105669964B (zh) * 2016-03-04 2017-11-21 博瑞生物医药（苏州）股份有限公司 卵巢癌特异靶向的生物可降解双亲性聚合物、由其制备的聚合物囊泡及应用
JP7104027B2 (ja) 2016-09-02 2022-07-20 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 淋菌に対するワクチン
AR113011A1 (es) 2017-09-08 2020-01-15 Evelo Biosciences Inc Vesículas extracelulares bacterianas
GB202115077D0 (en) 2021-10-21 2021-12-08 Glaxosmithkline Biologicals Sa Assay

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003105890A2 (en) * 2002-06-13 2003-12-24 Glaxosmithkline Biologicals S.A. Vaccine composition
WO2004019977A2 (en) * 2002-08-30 2004-03-11 Chiron Srl Improved bacterial outer membrane vesicles
JP2004512269A (ja) * 2000-07-27 2004-04-22 チルドレンズ　ホスピタル　アンド　リサーチ　センター　アット　オークランド 髄膜炎菌に起因する疾患に対する広域防御のためのワクチン
WO2004054611A1 (en) * 2002-12-16 2004-07-01 Nasjonalt Folkehelseinstitutt Meningococcal vaccine based on outer membrane proteins porb2 and pora

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2848965A1 (de) 1978-11-11 1980-05-22 Behringwerke Ag Verfahren zur herstellung von membranproteinen aus neisseria meningitidis und diese enthaltende vaccine
ES2145072T3 (es) * 1993-05-13 2000-07-01 American Cyanamid Co Preparacion y usos de proteinas de membranas externas carentes de los de cocos gramnegativos.
ES2128055T3 (es) * 1994-04-20 1999-05-01 Us Army Vacuna contra infecciones de bacterias gram-negativas.
US6180111B1 (en) * 1995-05-18 2001-01-30 University Of Maryland Vaccine delivery system
AU748973B2 (en) * 1997-07-17 2002-06-13 Baxter Healthcare Sa Immunogenic conjugates comprising a group B meningococcal porin and an H. influenzae polysaccharide
EP1741443B1 (en) 1998-05-29 2014-05-21 Novartis Vaccines and Diagnostics, Inc. Combination meningitidis B/C vaccines
ES2278446T3 (es) 1998-05-29 2007-08-01 Novartis Vaccines And Diagnostics, Inc. Vacunas combinadas b/c contra la meningitis.
GB9918319D0 (en) * 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
AU1917501A (en) 1999-11-12 2001-06-06 University Of Iowa Research Foundation, The Control of neisserial membrane synthesis
NO20002828D0 (no) 2000-06-02 2000-06-02 Statens Inst For Folkehelse Proteinholdig vaksine mot Neisseria meningtidis serogruppe samt fremgangsmÕte ved fremstilling derav
WO2003009869A1 (en) * 2001-07-26 2003-02-06 Chiron Srl. Vaccines comprising aluminium adjuvants and histidine
GB0130123D0 (en) * 2001-12-17 2002-02-06 Microbiological Res Agency Outer membrane vesicle vaccine and its preparation
DK2255826T3 (en) 2002-08-02 2016-06-20 Glaxosmithkline Biologicals Sa Neisserial vaccine compositions comprising a combination of antigens.
GB0227346D0 (en) * 2002-11-22 2002-12-31 Chiron Spa 741
US7031284B2 (en) * 2003-03-03 2006-04-18 Interdigital Technology Corporation Wireless communication method and apparatus for optimizing multi-user detection
GB0316560D0 (en) 2003-07-15 2003-08-20 Chiron Srl Vesicle filtration
US7628995B2 (en) 2003-12-23 2009-12-08 Glaxosmithkline Biologicals S.A. Outer membrane vesicles and uses thereof
US20090246224A1 (en) * 2006-06-12 2009-10-01 Nathalie Devos Vaccine

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004512269A (ja) * 2000-07-27 2004-04-22 チルドレンズ　ホスピタル　アンド　リサーチ　センター　アット　オークランド 髄膜炎菌に起因する疾患に対する広域防御のためのワクチン
WO2003105890A2 (en) * 2002-06-13 2003-12-24 Glaxosmithkline Biologicals S.A. Vaccine composition
WO2004019977A2 (en) * 2002-08-30 2004-03-11 Chiron Srl Improved bacterial outer membrane vesicles
WO2004054611A1 (en) * 2002-12-16 2004-07-01 Nasjonalt Folkehelseinstitutt Meningococcal vaccine based on outer membrane proteins porb2 and pora

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
JPN6011030459; Ｎｅｗ　Ｚｅａｌａｎｄ　Ｍｅｄｉｃａｌ　Ｊｏｕｒｎａｌ Ｖｏｌ．１１７，Ｎｏ．１２００, 200408 *
JPN6011030462; Ｖａｃｃｉｎｅ Ｖｏｌ．２２，Ｎｏ．１７-１８, 200406, ｐ２１７１-２１８０ *
JPN6011030464; ＦＥＭＳ　Ｉｍｍｕｎｏｌｏｇｙ　ａｎｄ　Ｍｅｄｉｃａｌ　Ｍｉｃｒｏｂｉｏｌｏｇｙ Ｖｏｌ．４１，Ｎｏ．３, 200407, ｐ２０５-２１０ *
JPN6011030465; Ｖａｃｃｉｎｅ Ｖｏｌ．２２，Ｎｏ．２３-２４, 200408, ｐ３００８-３０１３ *
JPN6014023666; Ｖａｃｃｉｎｅ Ｖｏｌ．１４，Ｎｏ．１０, 1996, ｐｐ．１００９-１０１５
JPN6014023876; Ｉｎｆｅｃｔｉｏｎ　ａｎｄ　Ｉｍｍｕｎｉｔｙ , 2003, ｐ．６３６７-６３７１

Also Published As

Publication number Publication date
NZ553521A (en) 2010-01-29
EP1784213A2 (en) 2007-05-16
US8808711B2 (en) 2014-08-19
CN101115501A (zh) 2008-01-30
WO2006024946A3 (en) 2006-11-30
AU2005278896B2 (en) 2011-12-22
GB0419627D0 (en) 2004-10-06
RU2420312C2 (ru) 2011-06-10
ES2527859T3 (es) 2015-01-30
US20080063665A1 (en) 2008-03-13
CA2578588A1 (en) 2006-03-09
MX2007002633A (es) 2007-05-15
AU2005278896A1 (en) 2006-03-09
CN101862451A (zh) 2010-10-20
EP1784213B1 (en) 2014-10-29
BRPI0514883A (pt) 2008-06-24
WO2006024946A2 (en) 2006-03-09
RU2007111838A (ru) 2008-10-10
JP2011236254A (ja) 2011-11-24

Similar Documents

Publication Publication Date Title
JP2011236254A (ja) 髄膜炎菌外膜ベシクルに関する改良
RU2475496C2 (ru) МЕНИНГОКОККОВЫЕ ПОЛИПЕПТИДЫ fHBP
JP6077983B2 (ja) 外膜タンパク質を有する免疫原性細菌小胞
JP5701058B2 (ja) 髄膜炎菌ワクチン処方物
US20130071422A1 (en) Adjuvanted vaccines for serogroup b meningococcus
JP2015110653A (ja) 髄膜炎菌ｆＨＢＰ配列を含むハイブリッドポリペプチド
JP2012512240A (ja) ヘモグロビン受容体を含む髄膜炎菌ワクチン
JP2012502013A (ja) 外膜小胞初回刺激−タンパク質追加免疫ワクチン
JP7650871B2 (ja) 免疫原性組成物
EA048463B1 (ru) Иммуногенные композиции
AU2013202593A1 (en) Adjuvanted vaccines for serogroup B meningococcus

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080820

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080820

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110613

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20110826

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120202

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120601

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20120720

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20120813

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20120928

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140110

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140116